The Sinopharm COVID-19 vaccine: What you need to know – World Health Organization

The WHO Strategic Advisory Group of Experts (SAGE) on Immunization has issued Interim recommendations for the use of the inactivated COVID-19 vaccine BIBP developed by Sinopharm/China National Pharmaceutical Group.
Here is what you need to know.
This article provides a summary of the interim recommendations; the interim recommendations and the background document are also available online.
Who should be vaccinated first?
While COVID-19 vaccine supplies are limited, health workers at high risk of…

Click here to view the original article.